Search results

Order by most recent / most popular / relevance

Results: 1-5 of 5

Dispelling the Myriad gene patent harmonization myth

Foley & Lardner LLP
-
Australia, Canada, European Union, France, Germany, Japan, USA
-
April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Australian Federal Court upholds Myriad’s gene patent

Morrison & Foerster LLP
-
Australia, USA
-
February 15 2013

While the question of patentability of isolated gene sequences awaits resolution at the U.S. Supreme Court, the Australian Federal Court today upheld

European Commission ups the cost of paying for delay

King & Wood Mallesons
-
Australia, European Union, USA
-
August 13 2012

On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram

The importance of good laboratory notebook practice

Davies Collison Cave
-
Australia, USA
-
October 18 2011

Take note: poor laboratory notebook documentation could cost you!

Competition regulators continue their campaign against pharmaceutical companies

King & Wood Mallesons
-
Australia, USA
-
June 1 2011

Last month, the US Federal Trade Commission (FTC) released its findings on reverse payment settlements between pharmaceutical companies in the 2010 US fiscal year

Search results

Dispelling the Myriad gene patent harmonization myth

Australian Federal Court upholds Myriad’s gene patent

European Commission ups the cost of paying for delay

The importance of good laboratory notebook practice

Competition regulators continue their campaign against pharmaceutical companies

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea